CEO: Raul R. Rodriguez
Employees: 162
IPO: Nov 29, 2000
Precio
$27.50
Cambio
▲ $0.46
1.70%
Cap. Mercado
508.01M
Rango del Día
$27.35
$28.23
Rango de 52 Semanas
$15.50
$52.24
Volumen
239,451
Promedio 50D / 200D
$31.80
$32.98
Cierre Anterior
$27.04
Quick Summary
Puntos Clave
Revenue grew 18.50% annually over 5 years — strong growth
Earnings grew 1999.08% over the past year
ROE of 185.94% indicates high profitability
Net margin of 124.72% shows strong profitability
Debt/Equity of 0.14 — conservative balance sheet
Generating 75.66M in free cash flow
Crecimiento
Revenue Growth (5Y)
18.50%
Above sector avg (9.60%)
Revenue (1Y)64.15%
Earnings (1Y)1999.08%
FCF Growth (3Y)N/A
Calidad
Return on Equity
185.94%
Above sector avg (3.61%)
ROIC21.16%
Net Margin124.72%
Op. Margin42.63%
Seguridad
Debt / Equity
0.14
Below sector avg (0.23)
Current Ratio2.42
Interest Coverage17.14
Valoración
P/E Ratio
1.38
Above sector avg (0.23)
Forward P/EN/A
P/B Ratio1.30
EV/EBITDA4.15
Dividend Yield0.00%
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (638 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 1.4 | 0.2 |
| P/B | 1.3 | 2.9 |
| ROE % | 185.9 | 3.6 |
| Net Margin % | 124.7 | 3.9 |
| Rev Growth 5Y % | 18.5 | 9.6 |
| D/E | 0.1 | 0.2 |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 64.15% | Revenue Growth (3Y) | 58.67% |
| Earnings Growth (1Y) | 1999.08% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 18.50% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 294.28M | Net Income (TTM) | 367.02M |
| ROE | 185.94% | ROA | 71.46% |
| Gross Margin | 93.33% | Operating Margin | 42.63% |
| Net Margin | 124.72% | Free Cash Flow (TTM) | 75.66M |
| ROIC | 21.16% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.14 | Current Ratio | 2.42 |
| Interest Coverage | 17.14 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 1.38 | Forward P/E | N/A |
| P/B Ratio | 1.30 | P/S Ratio | 1.73 |
| PEG Ratio | 0.00 | Forward PEG | N/A |
| EV/EBITDA | 4.15 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 14.89% | ||
| Market Cap | 508.01M | Enterprise Value | 520.73M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 294.28M | 179.28M | 116.88M | 120.24M | 149.24M |
| Net Income | 367.02M | 17.49M | -25.09M | -58.57M | -17.91M |
| EPS (Diluted) | 19.48 | 0.99 | -1.44 | -3.40 | -1.10 |
| Gross Profit | 274.66M | 160.63M | 109.77M | 118.49M | 148.15M |
| Operating Income | 125.47M | 24.19M | -20.49M | -55.55M | -12.50M |
| EBITDA | 127.88M | 28.51M | -16.98M | -53.87M | -11.29M |
| R&D Expenses | 33.30M | 23.38M | 24.52M | 60.27M | 65.24M |
| SG&A Expenses | 115.90M | 113.06M | 105.74M | 112.45M | 91.89M |
| D&A | 2.42M | 2.23M | 1.24M | 998,000.0 | 1.16M |
| Interest Expense | 7.32M | 7.92M | 6.87M | 3.71M | 4.86M |
| Income Tax | -245.20M | 881,000.0 | 0.0 | 0.0 | 605,000.0 |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 513.59M | 163.98M | 117.23M | 134.28M | 167.33M |
| Total Liabilities | 122.11M | 160.69M | 145.87M | 147.90M | 136.95M |
| Shareholders' Equity | 391.48M | 3.29M | -28.64M | -13.62M | 30.37M |
| Total Debt | 53.30M | 59.97M | 60.58M | 41.55M | 30.57M |
| Cash & Equivalents | 40.58M | 56.75M | 32.79M | 24.46M | 18.89M |
| Current Assets | 240.17M | 135.10M | 99.27M | 115.90M | 154.47M |
| Current Liabilities | 99.24M | 63.30M | 53.27M | 65.21M | 63.55M |
Puntuaciones de Estrategias
This stock passed the criteria for 5 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Capital Light Compounder
#6 of 223
#14 of 153
#62 of 200
Custom
Full Throttle
#113 of 141
Custom
Lower Risk
#22 of 136
Actividad Reciente
Entró
Capital Light Compounder
Apr 2, 2026
Entró
Growth Investing (Philip Fisher)
Apr 2, 2026
Entró
Value Investing (Warren Buffett)
Apr 2, 2026
Entró
Full Throttle
Apr 2, 2026
Entró
Lower Risk
Apr 2, 2026